Headquartered in the Johnson & Johnson Innovation centre, JLABS @ Toronto, at the MaRS Centre, the epicenter of medical innovation in Canada, where Avicanna’s 20+ scientists perform research with world class academic and clinical institutions.
Our Colombian cultivation subsidiaries aim to become global leaders in high quality and low cost mass production of cannabis extracts and purified cannabinoids, with a focus on organic and environmentally sustainable practices.
Our R&D and Cultivation activities are focused on the development of our four key products: plant-derived cannabinoid pharmaceuticals; phyto-therapeutics; derma-cosmetics; and, cannabis extracts and purified cannabinoids, with a goal of eventually having our products manufactured and distributed in various markets around the world.

A team of experienced management and scientific experts in the biopharmaceutical industry.